COVID-19 is an emerging, rapidly evolving situation. What people with cancer should know: https://www.cancer.gov/coronavirus. Get the latest public health information from CDC: https://www.coronavirus.gov. Get the latest research information from NIH: https://www.nih.gov/coronavirus.
This issue of CCR Milestones captures a few select highlights of this year's research activities.
An immunotherapy treatment strategy for advanced multiple myeloma shows promise in the clinic.
Mapping of metabolic changes reveals the proteins that are altered in kidney cancers, offering clues for how the disorder emerges.
Advanced imaging technology reveals surprising levels of differences in the genome of individual cells, which may have implications for treatment.
Cellular diversity may enable some liver tumors to reprogram their microenvironments and render immunotherapy less effective.
A newly discovered chemical modification to RNA allows cells to rapidly ramp up production of certain proteins.
New findings demonstrate the power of zebrafish for teasing out how migrating cancer cells sense and respond to physical cues in their environment.
New insights into the regulatory mechanisms of cilia formation could help explain their abnormalities in cancer.
Studies of the pediatric cancer rhabdomyosarcoma suggest a way to exploit the complexity of gene networks to intervene in cancer growth.
CCR researchers have developed new artificial intelligence tools that will help radiologists improve prostate cancer diagnosis.
A drug routinely used to prevent the adverse effects of bone marrow transplantation works differently than widely thought.
New faculty join CCR each year to contribute to our work of making breakthrough scientific discoveries to find cures and treatments for cancer.
We are proud of our CCR awardees who represent a spectacular array of accomplishments.
Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening in CCR.
A list of CCR Resources.
